Skip to main content
See every side of every news story
Published loading...Updated

Blood Test for Colon Cancer Improves Chemotherapy Decisions, Study Finds

The study demonstrated that patients who test positive for ctDNA “actually benefit from chemotherapy.” The CIRCULATE study, a randomized trial involving more than 2,100 patients, has demonstrated that testing for circulating tumor DNA (ctDNA) can improve treatment decisions for colon cancer. Published in Annals of Oncology, the research confirms that ctDNA is a significant risk marker and that patients testing positive for these DNA fragments be…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Clinical Lab Products broke the news on Friday, June 5, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal